Thailand · Delayed Price · Currency is THB BKK:KLINIQ Statistics
Total Valuation
BKK:KLINIQ has a market cap or net worth of THB 4.40 billion. The enterprise value is 4.41 billion.
| Market Cap | 4.40B |
| Enterprise Value | 4.41B |
Important Dates
The last earnings date was Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | Aug 26, 2025 |
Share Statistics
BKK:KLINIQ has 220.00 million shares outstanding. The number of shares has increased by 0.59% in one year.
| Current Share Class | 220.00M |
| Shares Outstanding | 220.00M |
| Shares Change (YoY) | +0.59% |
| Shares Change (QoQ) | -0.58% |
| Owned by Insiders (%) | 65.86% |
| Owned by Institutions (%) | 1.60% |
| Float | 62.92M |
Valuation Ratios
The trailing PE ratio is 12.55 and the forward PE ratio is 11.35. BKK:KLINIQ's PEG ratio is 1.16.
| PE Ratio | 12.55 |
| Forward PE | 11.35 |
| PS Ratio | 1.30 |
| PB Ratio | 2.63 |
| P/TBV Ratio | 2.65 |
| P/FCF Ratio | 16.48 |
| P/OCF Ratio | 7.91 |
| PEG Ratio | 1.16 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.65, with an EV/FCF ratio of 16.52.
| EV / Earnings | 12.54 |
| EV / Sales | 1.30 |
| EV / EBITDA | 5.65 |
| EV / EBIT | 9.64 |
| EV / FCF | 16.52 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.39.
| Current Ratio | 1.24 |
| Quick Ratio | 0.75 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | 0.85 |
| Debt / FCF | 2.47 |
| Interest Coverage | 17.79 |
Financial Efficiency
Return on equity (ROE) is 21.40% and return on invested capital (ROIC) is 12.58%.
| Return on Equity (ROE) | 21.40% |
| Return on Assets (ROA) | 9.31% |
| Return on Invested Capital (ROIC) | 12.58% |
| Return on Capital Employed (ROCE) | 20.83% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.10 |
| Inventory Turnover | 5.49 |
Taxes
In the past 12 months, BKK:KLINIQ has paid 91.03 million in taxes.
| Income Tax | 91.03M |
| Effective Tax Rate | 20.55% |
Stock Price Statistics
The stock price has decreased by -32.20% in the last 52 weeks. The beta is -0.06, so BKK:KLINIQ's price volatility has been lower than the market average.
| Beta (5Y) | -0.06 |
| 52-Week Price Change | -32.20% |
| 50-Day Moving Average | 26.06 |
| 200-Day Moving Average | 26.17 |
| Relative Strength Index (RSI) | 19.92 |
| Average Volume (20 Days) | 430,448 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BKK:KLINIQ had revenue of THB 3.39 billion and earned 351.56 million in profits. Earnings per share was 1.59.
| Revenue | 3.39B |
| Gross Profit | 1.73B |
| Operating Income | 457.54M |
| Pretax Income | 443.04M |
| Net Income | 351.56M |
| EBITDA | 652.75M |
| EBIT | 457.54M |
| Earnings Per Share (EPS) | 1.59 |
Balance Sheet
The company has 658.37 million in cash and 659.74 million in debt, giving a net cash position of -1.37 million or -0.01 per share.
| Cash & Cash Equivalents | 658.37M |
| Total Debt | 659.74M |
| Net Cash | -1.37M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 1.67B |
| Book Value Per Share | 7.56 |
| Working Capital | 213.11M |
Cash Flow
In the last 12 months, operating cash flow was 556.15 million and capital expenditures -289.15 million, giving a free cash flow of 266.99 million.
| Operating Cash Flow | 556.15M |
| Capital Expenditures | -289.15M |
| Free Cash Flow | 266.99M |
| FCF Per Share | 1.21 |
Margins
Gross margin is 51.21%, with operating and profit margins of 13.51% and 10.38%.
| Gross Margin | 51.21% |
| Operating Margin | 13.51% |
| Pretax Margin | 13.08% |
| Profit Margin | 10.38% |
| EBITDA Margin | 19.28% |
| EBIT Margin | 13.51% |
| FCF Margin | 7.88% |
Dividends & Yields
This stock pays an annual dividend of 1.40, which amounts to a dividend yield of 7.00%.
| Dividend Per Share | 1.40 |
| Dividend Yield | 7.00% |
| Dividend Growth (YoY) | 3.57% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 90.74% |
| Buyback Yield | -0.59% |
| Shareholder Yield | 6.37% |
| Earnings Yield | 7.99% |
| FCF Yield | 6.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |